GlassScriptPhysician profile
Douglas David Davies
NPI 1326073222
$12,877.27
in general payments reported to CMS, 2019-2025
68 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,583 · 2020: $1,665 · 2021: $1,676 · 2022: $1,471 · 2023: $1,676 · 2024: $2,780 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,482.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $4,495.46 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Abbvie INC. | $906.00 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $764.32 | 2019-2024 | Wegovy |
| Amgen INC. | $542.80 | 2019-2025 | Repatha, Otezla, Otezla |
| Janssen Biotech, INC. | $474.62 | 2019-2022 | |
| Lilly USA, LLC | $439.14 | 2019-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $377.53 | 2019-2025 | Pifeltro, Delstrigo, Capvaxive |
| Emd Serono, INC. | $367.69 | 2020-2025 | |
| Bausch Health US, LLC | $291.17 | 2019-2025 | Aplenzin |
| Pfizer INC. | $248.63 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $239.49 | 2019-2023 | Ajovy |
| Sunovion Pharmaceuticals INC. | $224.50 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $207.56 | 2020-2025 | Trintellix |
| Theratechnologies INC. | $190.67 | 2019-2025 | Egrifta, Trogarzo |
| Jazz Pharmaceuticals INC. | $172.33 | 2022-2025 |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.